Davis Polk & Wardwell advised the several initial purchasers on the offering.Immunocore Holdings plc (Immunocore) (Nasdaq: IMCR) announced the pricing of $350.0 million aggregate principal amount of…
Immunocore Holdings’ $402.5 Million Convertible Notes Offering
![](https://globallegalchronicle.com/wp-content/uploads/2024/02/immunocore-holdings-402-5-million-convertible-notes-offering_65e035a613388.jpeg)